Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study. [electronic resource]
Producer: 20180813Description: 57-66 p. digitalISSN:- 1879-0852
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Neoplasms -- drug therapy
- Child
- Child, Preschool
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Diphosphonates -- administration & dosage
- Doxorubicin -- administration & dosage
- Etoposide -- administration & dosage
- Female
- France
- Humans
- Ifosfamide -- administration & dosage
- Imidazoles -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Methotrexate -- administration & dosage
- Neutropenia -- chemically induced
- Osteosarcoma -- drug therapy
- Young Adult
- Zoledronic Acid
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.